News
Jun 4, 2021
Apr 19, 2021
Research, Sponsored Programs, and Innovation Financial Conflict of Interest in Research Policy
Sep 24, 2020
Aug 22, 2020
Researchers discover promising remedy to battle epidemic of liver disease
Aug 10, 2020
Nature Communications Editors’ Highlights
July 9, 2020
New, Promising Therapy to Fight Epidemic of Liver Disease Discovered
July 8, 2020
Inhibition of MCJ Transmembrane Protein Studied as NAFLD Treatment
July 7, 2020
Researchers Find Promising Therapy to Fight Epidemic of Liver Disease
July 3, 2020
Publications
Barbier-Torres., et al., Silencing Hepatic MCJ attenuates NAFLD by increasing mitochondrial fatty acid oxidation. Nature Communications., Jul 2020., (11) 3360., 1-15. https://pubmed.ncbi.nlm.nih.gov/32620763/
Barbier-Torres., et al., The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury. Nature Communications., Dec 2017., (8) 2068., 2-11. https://pubmed.ncbi.nlm.nih.gov/29233977/
Champagne D.P., et al., Fine-Tuning of CD8+ T Cell Mitochondrial Metabolism by the Respiratory Chain Repressor MCJ Dictates Protection to Influenza Virus. Immunity., Jun 2016., (44). 1299-1311. https://pubmed.ncbi.nlm.nih.gov/27234056/
Hatle K.M., et al., MCJ/DnaJC15, an Endogenous Mitochondrial Repressor of the Respiratory Chain That Controls Metabolic Alterations. Jun 2013., Vol 33 (11)., 2302-2314. https://pubmed.ncbi.nlm.nih.gov/23530063/